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Abstract.  The leukocyte CDll/CD18 adhesion mole- 
cules (/32 integrins) are a  family of three heterodimeric 
glycoproteins each with a  distinct o~ subunit (CDlla, 
b, or c) and a  common ~  subunit (CD18).  CDll/CD18 
mediate crucial leukocyte adhesion functions such as 
chemotaxis, phagocytosis, adhesion to endothelium, 
aggregation, and cell-mediated cytotoxicity. The en- 
hanced cell adhesion observed upon activation of ieu- 
kocytes is associated with increased surface membrane 
expression of CDll/CD18,  as well as a  qualitative up- 
regulation of CDll/CD18 functions. To elucidate the 
nature of the qualitative modifications that occur, we 
examined the phosphorylation status of these mole- 
cules in resting human leukocytes and upon activation 
with PMA or with the chemotactic peptide F-met-leu- 
phe (FMLP). In unstimulated cells, all three CDll 
subunits were found to be constitutively phos- 
phorylated. In contrast, phosphorylation of the com- 
mon CD18  subunit was minimal. PMA induced rapid 
and sustained phosphorylation of CD18 that occurred 
at high stoichiometry, but had only minimal effects on 
phosphorylation of the associated CDll  subunits. 
FMLP also induced rapid phosphorylation of CD18, 
but the effect was of short duration. FMLP-induced 
phosphorylation of CD18 was not related to its Ca  +÷- 
mobilizing effect, as CD18 phosphorylation was not 
observed upon treatment of leukocytes with the Ca  +÷ 
ionophore, ionomycin. Phosphoamino acid analysis of 
CDll/CD18  in PMA- or FMLP-treated monocytes re- 
vealed a predominance of phosphoserine residues in 
all CDll/CD18  subunits. A  small component of phos- 
phothreonine was present in CDllc and CD18 and a 
minor component of phosphotyrosine was also de- 
tected in CD18.  We conclude that phosphorylation of 
CD18 upon leukocyte activation may regulate the adhe- 
sion functions mediated by the CDll/CD18  family of 
molecules. 
T 
HE leukocyte differentiation antigens CDll/CD18 are 
a  family of three  related glycoprotein heterodimers 
implicated in a variety of leukocyte adhesion processes 
(Dana and Arnaout,  1988).  CDll/CD18 glycoproteins are 
members of a larger family of or/3 heterodimeric adhesion 
molecules known as integrins (Hynes, 1987). These include 
the fibronectin receptor/VLA antigens (/$1 integrin subfam- 
ily), CDll/CD18 (/~2 integrin subfamily), and the vitronectin 
and gplIb/IIIa receptors (/$3 integrin subfamily). Each mem- 
ber of the CDll/CD18 family is a heterodimer consisting of 
a distinct c~ subunit (CDlla, b, and c, 180, 155, and 140 kD, 
respectively) non-covalently associated with an identical 94- 
kD common/3 subunit (CDI8). CDlla/CD18 (LFA-1) is ex- 
pressed on all leukocytes, and serves as a general adhesion 
molecule involved in leukocyte homotypic and heterotypic 
interactions (Patarroyo et al.,  1985;  Howard et al.,  1986; 
Rothlein and Springer, 1986; Arnaout et al., 1988a).  CD1 la/ 
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CD18 plays a particularly important role in vitro in the pro- 
liferation of T cells to antigens and mitogens (Berzins et al., 
1988; Schwartz et al., 1989),  in the interaction of cytotoxic 
T  cells and NK cells with their target cells (Davignon et 
al.,  1981; Schmidt et al., 1985),  in the activation of B cells 
and their differentiation into immunoglobulin-secreting cells 
(Howard et al.,  1986;  Fisher et al.,  1986),  and in leuko- 
cyte-endothelium adhesion (Mentzer et al.,  1986; Arnaout 
et al.,  1988a).  CDlla/CD18 adhesion functions are in part 
mediated by CD54, an endogenous ligand with wide cell dis- 
tribution  (Dustin  et  al.,  1986;  Simmons  et  al.,  1988). 
CDllb/CD18  (Mol) and CDllc/CD18 (p150/95)  are selec- 
tively expressed on granulocytes, monocytes, and NK cells. 
Both promote a  variety of leukocyte adhesive interactions 
such as phagocytosis, chemotaxis, aggregation, adhesion to 
endothelium, and binding to the complement C3 fragment 
iC3b (Arnaout et al., 1983, 1985, 1988a;  Micklem and Sim, 
1985;  Dana et al.,  1986;  Keizer et al.,  1987).  The impor- 
tance of CDll/CD18 antigens in the adhesive functions of 
leukocytes has been highlighted by the identification of a hu- 
man immunodeficiency disease characterized by recurrent 
severe bacterial infections in which leukocytes are deficient 
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dependent functions displayed by the leukocytes of these 
patients,  including chemotaxis, leukoaggregation, iC3b bind- 
ing, adhesion to endothelium, and phagocytosis are all uni- 
formly defective (Dana and Arnaout,  1988). 
The adhesive properties of CDll/CD18 are significantly 
enhanced after leukocyte activation with a variety of inflam- 
matory mediators (Arnaout et al., 1984; Berger et al., 1984; 
Patarroyo et al.,  1985;  Rothlein and Springer,  1986).  In 
polymorphonuclear leukocytes, granulocytes (PMNs) ~  and 
monocytes, cell activation is also associated with increased 
expression of CDllb,c/CD18 on the cell surface (Arnaout et 
al., 1984; Berger et al., 1984; Freyer et al., 1988),  suggest- 
ing one mechanism for stimulus-induced enhancement of 
leukocyte adhesion. There is also evidence that qualitative 
changes in these molecules are crucial for mediating adhe- 
sion upon cellular activation. Treatment of lymphocytes  with 
the protein kinase C (PKC) activator PMA led to rapid induc- 
tion of CDlla/CD18-dependent aggregation without an ap- 
parent increase in CD11a/CD18  surface expression (Patar- 
royo et al.,  1985; Rothlein and Springer,  1986).  Treatment 
of PMN with PMA resulted in the sequential activation and 
deactivation of CDIlb/CD18 adhesive functions in a manner 
that could not be accounted for by quantitative alterations in 
the  receptor's  surface  membrane  expression  (Wright  and 
Meyer, 1986). Similarly, phagocytosis of iC3b-coated sheep 
erythrocytes  by monocytes required stimulation of  these cells 
with tumor-promoting phorbol esters  (Wright and Silver- 
stein, 1982). Other studies have demonstrated that the adhe- 
sive functions of CDllb/CD18 in PMN can be dissociated 
from stimulus-induced increase in  surface membrane ex- 
pression of this heterodimer (Buyon et al., 1988; Vedder and 
Harlan, 1988). Similarly, treatment of monocytes with ADP 
resulted in exposure of new epitopes on CD1 lb/CD18 and its 
acquiring of new functional specificities without a quantita- 
tive increase in its surface membrane expression (Altieri and 
Edington,  1988).  These  studies  suggest that CDll/CD18 
adhesive functions can be qualitatively altered upon trans- 
membrane signaling, and support a  role for PKC-induced 
phosphorylation event(s)  in regulating these functions. 
One potential target for PKC-mediated phosphorylation is 
CDll/CD18 itself. Examination of published cDNA-derived 
amino acid sequences of  human CDlla (Larson et al., 1989), 
CDllb (Arnaout et al., 1988b),  CDllc (Corbi et al., 1987), 
and CD18 (Kishimoto et al., 1987; Law et ~., 1987) reveals 
available serine, threonine, and tyrosine residues in various 
combinations in the cytoplasmic domains of all four proteins 
(Fig. 1). These residues may serve as putative phosphoryla- 
tion sites for serine/threonine-specific protein kinases, in- 
cluding PKC, as well as for tyrosine-specific  protein kinases. 
Interestingly, the cytoplasmic domain of CD18 contains mul- 
tiple basic amino acids distributed on both sides of serine 
residues,  a  feature characteristic of potent PKC  substrate 
peptides (House, 1987).  Previous studies aimed at looking 
for evidence of CDll/CDI8 phosphorylation upon PKC acti- 
vation by phorbol esters arrived at conflicting conclusions. 
While one study found that PMA induced phosphorylation 
ofCD18 (Hara and Fu, 1986), two other studies failed to sup- 
1. Abbreviations  used in this paper:  [Ca++]i,  intracellular free Ca  ++ con- 
centration; DAG, diacyiglycerol; FMLE F-met-leu-phe; PBMC, peripheral 
blood mononuclear cell: PKC, protein kinase C; PMN,pol2/morphonuclear 
leukocyte granulocyte; RAMIG,  rabbit anti-mouse IgG. 
port that conclusion (Changelian and Fearon, 1986; Skubitz 
et al.,  1988).  In the present study, we examined the phos- 
phorylation status of all three CDI1/CD18 heterodimers in 
human monocytes and PMN, both at rest and after stimula- 
tion with PMA or F-met-leu-phe (FMLP), both of which en- 
hance  CDll/CD18-mediated  adhesion  functions  in  these 
cells. We found that all three t~ subunits were constitutively 
phosphorylated and that PMA or FMLP induced a major in- 
crease in phosphorylation of CD18 that was dose and time 
dependent. Both stimuli induced a small increase in the in- 
trinsic phosphorylation of CDll.  Stimulus-induced phos- 
phorylation of CD18 may play an important role in mediating 
the various functions dependent on this group of leukocyte 
adhesion molecules. 
Materials and Methods 
Reagents 
The  following murine mAbs recognizing the various subunits of CDll/ 
CD18  were  used:  mAb TS1/22  directed against CDIla  (Mentzer et al., 
1986); mAb 44a (IgG 2a), directed against CDilb (Todd et al.,  1981; Dana 
et al.,  1984); mAb L29 (IgG I), directed against CDlle (Arnaout et al., 
1988a); and mAb 10F12 (IgG 1), directed against CDI8 (Rosemarin et al., 
1989).  PMA  and  ionomycin  were  obtained  from  Calbiochem-Behring 
Corp.  (La Jolla, CA).  FMLP,  crystalline BSA (globulin free), leupeptin, 
pepstatin, chymostatin, antipain, iodoacetic acid, Hepes, PMSE and phos- 
phoamino acids were from Sigma Chemical Co. (St. Louis, MO). Protein 
A-Sepharose was purchased from Pharmacia Fine Chemicals (Piscataway, 
NJ). Rabbit anti-mouse IgG (RAMIG) was obtained from PeI-Freeze Bio- 
logicals (Rogers, AR), 32p-orthophosphate, HCl-free, and 1251 carrier-free 
were from New England Nuclear (Boston, MA). 
Cells 
Peripheral blood mononuclear cells (PBMCs) were obtained from healthy 
individuals by leukopheresis and were depleted of contaminating red blood 
cells and PMN by centrifugation over Ficoll-Hypaque. Monocytes were iso- 
lated by adhering PBMCs to petri dishes as described (Todd et ai.,  1981). 
The purified monocyte preparations were usually >90 % positive for CDllb/ 
CDI8 by immunofluorescence. Human PMNs were purified from periph- 
eral blood by centrifugation over Ficoll-Hypaque and hypotonic lysis as de- 
scribed (Dana et al.,  1984). 
~2p Radiolabeling, lmmunoprecipitation, and 
Gel Electrophoresis 
Cells were washed three times in a phosphate-free medium containing 30 
mM Hepes,  110 mM NaCI,  110 mM glucose, 5 mM KCI,  1 mM CaCl2, 
1 mM MgCI2, and 2 mg/ml BSA, pH 7.4. Cells were resuspended at 2.5  × 
107 cells/ml in the same buffer and incubated for  1 h  at 37°C, pelleted, 
resuspended  as above,  and  incubated in the presence of  1 mCi/ml  32p_ 
orthophosphate for 3 h at 37°C. Thereafter, cells were washed, resuspended 
in fresh phosphate-free buffer at 37°C, and stimulated with the desired agent 
for the indicated times. Cell activation was terminated by pelleting the cells 
for 10 s in a microcentrifuge (8,000 g), and resuspending them in ice-cold 
lysis buffer containing 20 mM Tris-HCl, 250 mM NaCI, 50 mM NaH2PO4, 
50 mM  NaF,  25  mM  Na4P2OT, 10 mM iodoacetic acid,  5  mM  EDTA, 
5 mM EGTA,  1 mM PMSF,  1 mM Na3VO4,  1% NP-40, and 1 mg/ml each 
of leupeptin, pepstatin, chymostatin, and antipain at pH 7.4 (lysis buffer). 
Cell lysates were spun down at 15,000 g for 30 min at 4°C, and supernatants 
were precleared by incubating them with 25/tl of packed protein A-Sepha- 
rose sequentially precoated with RAMIG followed by normal mouse serum. 
CDll/CD18  antigens were thereafter precipitated by  incubating the pre- 
cleared lysates for 4 h with 25 #l of protein A-Sepharose sequentially coated 
with RAMIG and the respective anti-CD1 la, b, c, or CDI8 mAb. Sepharose 
beads were then pelleted and washed five times with BSA-free lysis buffer. 
Immunoprecipitates were solubilized with 25/,d of an SDS sample buffer 
containing 2 % SDS, 10% glycerol, 100 mM Tris-HCI, pH 6.8, 0.1 M 2-mer- 
captoethanol, and 0.02 % bromophenol blue. Samples were electrophoresed 
on polyacrylamide gels using the system of Laemmli  (1970).  Gels were 
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showing the overall structure 
of CDII/CDI8 and the amino 
acid  sequences  of  the  cyto- 
plasmic  end  of each  subunit 
(derived from published data). 
The larger CDII  subunits are 
homologous and contain seven 
tandem  repeats  (horizontal 
bars), three of which contain 
putative  metal-binding  sites 
(*),  and  an  adhesion-related 
domain  (A-domain)  with ho- 
mologies to several collagen- 
binding proteins  (Arnaout et 
al.,  1988b; Pytela, 1988). The 
smaller  common  CDI8  sub- 
unit contains a unique cysteine- 
rich motif repeated four times. 
TM,  transmembrane  region. 
C,  cytoplasmic end.  The po- 
tential  phosphorylation  sites 
corresponding  to  serine  (S), 
threonine  (T),  and  tyrosine 
(Y) residues are in bold letters. 
dried and exposed  to x-ray film (XAR-5; Eastman Kodak Co., Rochester, 
NY) with intensifying  screen (Dupont Co., Wilmington,  DE). The relative 
degree of phosphorylation in the labeled bands of interest was determined 
by scanning the radiograms under conditions of linear exposure using a den- 
sitometer (Ultroscan 2; LKB Instruments, Inc., Gaithersburg, MD) and cor- 
recting for band width. 
Phosphoamino Acid Analysis 
Phosphoamino acid analysis was carried out as described (Avruch et al., 
1982). Immunoprecipitates  from PMA- or FMLP-treated 32p-labeled mono- 
cytes were electrophoresed on polyacrylamide gels as described above. Gels 
were dried and subjected to autoradiography.  Regions in the gel correspond- 
ing to CDIIa, b, c, and CDI8 were excised,  rehydrated,  and extracted  in 
1% SDS overnight  at 37°C. BSA was added to each extract (0.5 mg]ml), and 
proteins were precipitated with 5 vol of acetone at -20°(2. After two washes, 
the pellets were  dried and subjected  to acid hydrolysis  (6 N  HCI,  2  h, 
I I0°C). Each hydrolysate was separately  subjected to two-dimensional  thin 
layer electrophoresis on cellulose.  Electrophoresis in the first dimension 
was done in formic acid/acetic acid/H20 (25:87:888)  buffer, pH 3.5, for 
4 h at 800 V; electrophoresis in the second dimension was performed in 
pyridine/acetic acid/H20 (1:10:89) buffer for 2 h at 800 V. Added  phos- 
phoamino acid standards were visualized  by spraying the plates with nin- 
hydrin, while radiolabeled phosphoamino acids were visualized by autora- 
diography  as described above. 
Stoichiometry of  Phosphorylation 
Aliquots each consisting of 5  ×  107 washed monocytes were resuspended 
in 0.5 ml of ice-cold PBS containing 1 mM MgCl2 and 100 #g lactoperoxi- 
dase (Sigma Chemical Co.), and surface  labeled by addition of 1 mCi of 
carrier-free 1251 (New England Nuclear), followed by six additions of l0 #l 
of  1:1,000 dilution of hydrogen  peroxide  (37%  solution) over a  30-min 
period. Reaction was stopped by addition of PBS, containing l mM sodium 
iodide and saturating amounts of tyrosine.  After tv~ washes, cell aliquots 
(in Hanks' buffer, pH 7.4) were  either exposed  to 250 ng/ml PMA or to 
buffer alone (as a control) for 10 min at 37°(2. Cells were then washed, solu- 
bilized in lysis buffer, and immunoprecipitated  with anti-CDt lb mAb as de- 
scribed above.  Immunoprecipitates  from one PMA-treated  sample were 
eluted from the immunoadsorbant by boiling in 1% SDS and the eluate was 
either mock4reated or treated with bacterial alkaline phosphatase (molecu- 
lar biology grade,  Boehringer Mannheim Biochemicals,  Indianapolis,  IN) 
exactly  as  described  (Krangel,  1987).  Eluates  were  analyzed  by  two- 
dimensional gel electrophoresis (first dimension, IEE using equal volumes 
of pH 3.5-t0 and pH 5-7 ampholines [O'Farrell et al., 1977]; second dimen- 
sion, 7.5% PAGE [Laemmli, 1970]). Radioactive species were identified by 
autoradiography  of the dried gels using film (XAR-5;  Eastman Kodak Co.) 
with an intensifying screen.  Quantitation of relative band intensity was per- 
formed by densitometric scanning of the radiograms under conditions of lin- 
ear exposure  using a densitometer (Ultroscan 2; LKB Instruments). 
Results 
Phosphorylation of CDll/CD18 Antigens in 
Human Monocytes 
Under basal conditions, immunoprecipitation of 32p-labeled 
monocytes using  mAbs  directed against  CDlla,  b,  c,  or 
CD18 subunits followed by SDS-PAGE revealed that all three 
ot subunits were constitutively phosphorylated (Figs. 2 and 
3  A).  Little or no phosphorylation of the common CD18 
subunit  was  seen  under  these  conditions.  Treatment  of 
monocytes with PMA at 250 ng/ml for 1-15 min resulted in 
a dramatic phosphorylation of  CDlg with only small changes 
in the phosphorylation status of the associated u  subunits 
(Figs. 2  and 3 A). 
Kinetics of  PMA-induced Phosphorylation of  CD18 
The time course and concentration dependence of PMA- 
induced  phosphorylation  of CD18  were  examined  using 
CD1 lb-associated CD18 as a prototype. Treatment of mono- 
cytes with PMA at a concentration of 250 ng/ml resulted in 
rapid phosphorylation of CD18 (Fig. 3 A). CD18 was nearly 
maximally phosphorylated by 1 min after PMA addition and 
remained so for the entire study period of 30 min. Constitu- 
tive phosphorylation of CD1 lb on the other hand showed 
only a  small  rise over this  time period (Fig.  3 A).  PMA- 
induced CDI8 phosphorylation was also concentration de- 
pendent being notable at 10 ng/ml of PMA, the lowest con- 
centration tested, and plateaued at ,'-,100 ng/ml (Fig. 3 B). 
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SDS-PAGE showing the  phosphoryla- 
tion  status of CDI1/CDI8  antigens in 
32P-loaded monocytes before  (-)  and 
after  (+)  stimulation with  PMA  (250 
ng/ml,  15  rain,  37°C). The  subunit- 
specific mAbs TS1/22  (anti-CDl la), L29 
(anti-CDllc),  and  10FI2 (anti-CD18) 
used to immunoprecipitate the  respec- 
tive antigens are indicated. None of the 
radiolabeled  bands  precipitated  with 
anti-CDll/CD18 mAbs were seen when 
a control nonreactive mAb was used. M 
represents the following molecular mass 
markers  (arrowheads): myosin (200 
kD),  phosphorylase b (92.5 kD),  BSA 
(68 kD), and ovalbumin (46 kD). 
Stoichiometry of  PMA-induced 
CDII/CDI8 Phosphorylation 
To determine the percentage of CD18 species that is phos- 
phorylated after PMA treatment, CDllb/CD18 immunopre- 
cipitates  from PMA-activated or resting  surface-iodinated 
monocytes were analyzed by two-dimensional IEF-PAGE. 
Resting cells displayed two major t25I-labeled CD18 bands 
(apparent molecular mass, 94 kD) (Fig. 4 A). The more basic 
species was predominant (74% of total).  CDllb  (apparent 
molecular mass,  155 kD), migrated as a broad band (Fig. 4 
A). Upon PMA treatment, the CD18 acidic species became 
predominant (73 % of total CD18-related radioactivity) (Fig. 
4  B).  No significant change in CDllb  was observed after 
PMA activation by this analysis (Fig. 4, A and B). Alkaline 
phosphatase treatment of a sample from PMA-induced cells 
resulted in a 70% drop in the radioactivity associated with 
the acidic form of CD18 and a 49% increase in that associ- 
ated  with  the basic  form (not shown),  indicating that the 
charge differences observed in CD18 after PMA treatment 
are predominantly due to phosphorylation. Alkaline phos- 
phatase treatment similarly resulted in a  shift of the broad 
CDI lb-associated band to a more basic form (data not shown). 
Phosphorylation of  CD18 by FMLP 
The chemotactic peptide FMLP, like PMA, enhances CD11/ 
CD18-mediated adhesion of phagocytic cells to various tar- 
gets (Arnaout et al.,  1984; Dana et al.,  1986), although its 
adhesion-promoting effects tend to be more transient (Boxer 
et al.,  1979).  We therefore examined the effect of FMLP 
treatment  of monocytes on  the  phosphorylation status  of 
CDll/CD18  antigens  using  CDllb/CD18  as  a  prototype. 
Treatment of monocytes with FMLP at 10  -7 M for 30 s in- 
duced phosphorylation of CD18 without significantly alter- 
ing intrinsic CDllb phosphorylation (Fig. 5). FMLP-induced 
CD18  phosphorylation was  transient  (Fig.  5),  peaking  at 
30 s, the earliest time point examined, and was almost com- 
pletely reversed by 5 min after stimulation. 
FMLP acts via its surface receptor to induce phospholi- 
pase C activation resulting in inositol trisphosphate and di- 
acylglycerol (DAG) accumulation and leading respectively to 
Ca  ++ mobilization and PKC activation (Becker,  1986; Ber- 
ridge,  1987).  We  found  the  FMLP-induced  CD18  phos- 
phorylation was not a direct consequence of its increasing the 
intracellular  free  Ca  ++  concentration  ([Ca++]i) in  treated 
cells.  This was evidenced by the failure of the Ca  ++ iono- 
phore,  ionomycin to  induce  phosphorylation of CD18  in 
monocytes when used at a concentration of 50 nM (Fig. 6). 
At this concentration, we found that ionomycin induces an 
increase in [Ca++]~ comparable to or even exceeding that ob- 
served with FMLP at 10  -6 M without significantly affecting 
phospholipase  C  activity  (our  unpublished  observations). 
These data suggest that FMLP-induced phosphorylation of 
CDI8 is predominantly mediated by intracellular accumula- 
tion of DAG, a major physiologic PKC activator (Bell 1986; 
Berridge,  1987). 
Constitutive and Stimulus-induced Phosphorylation of 
CDI1/CD18 in Human Granulocytes 
To determine if similar changes in CDI 1/CD18 phosphoryla- 
tion also occur in circulating PMN, we examined the phos- 
phorylation status of CDll/CD18 antigens in human PMN 
both at rest and upon activation with PMA or FMLP.  Fig. 
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CDIIb/CDI8  in  human  monocytes.  In  this 
figure and subsequent figures, the anti-CDllb 
mAb, 44, was used for immunoprecipitations. 
(A) Time course of PMA (250 ng/ml)-induced 
phosphorylation  of CDllb/CDI8.  Each  time 
point represents the mean +  SD of two sepa- 
rate  experiments.  Changes  in  CDll/CDI8 
phosphorylation were quantitated by densito- 
metric scanning of  autoradiographs. In this and 
subsequent figures, a baseline value of 100 was 
assigned  for CD18 and  [~2P]-CDIIb. In  the 
case of CDI8, this value was derived by scan- 
ning the area of the gel (in the uninduced con- 
trol sample) corresponding to that which con- 
mined  stimulus-induced  [32p]-CD18. (Inset) 
Autoradiograph  of  a  7.5% SDS-polyacryl- 
amide gel showing CDl8-induced phosphoryla- 
tion after 1 min of monocyte exposure to PMA 
(250 ng/ml, 37°C). -  and +  indicate CDllb/ 
CD18 immunoprecipitates in the  absence or 
presence of PMA, respectively. The positions 
of the molecular mass markers myosin (200 
kD), phosphorylase b (92.5 kD), and BSA (68 
kD) are indicated. (B) Histogram showing the 
degree  of phosphorylation  of CD18 (y-axis) 
upon treatment of 32P-loaded monocytes with 
increasing  concentrations  of PMA  (x-axis). 
CDl8-induced phosphorylation reached a pla- 
teau at ~100 ng/ml of PMA.  Each histogram 
represents mean + SD of two independent ex- 
periments. 
7 demonstrates that, in 32P-loaded PMN, CDllb is constitu- 
tively  phosphorylated  with  minimal  phosphorylation  of 
CD18. Treatment of PMN with PMA at 30 ng/ml induced a 
dramatic rise in phosphorylation of CD18 which peaked 30 
min after addition of PMA (Fig.  7 A).  FMLP, at  10  -7 M, 
also induced phosphorylation of CD18 which peaked at 30 s, 
the earliest time point studied, and declined by 5 min after 
FMLP addition  (Fig.  7  B).  In contrast to the marked in- 
crease in CD18 phosphorylation, only a modest 1.6-fold rise 
in  CDllb  phosphorylation was  seen after PMA treatment 
(Fig. 7 A). Basal as well as PMA- or FMLP-induced phos- 
phorylation of CDlla/CD18 and CDllc/CD18 in PMN fol- 
lowed a similar pattern to that observed for these antigens in 
monocytes (data not shown). 
Phosphoaraino Acid Analysis of  Phosphorylated 
CDll/CD18 Species 
To identify the amino acid(s) phosphorylated in CDI 1/CDI 8 
subunits in response to PMA or FMLP, regions encompass- 
ing each of the phosphorylated subunits were excised from 
polyacrylamide gels, eluted, precipitated, and subjected to 
acid hydrolysis and two-dimensional thin layer electrophore- 
sis. The amounts of 32p subjected to thin layer electrophore- 
sis were directly proportional to the counts detected in the 
gel slices before elution (data not shown). Both PMA- and 
FMLP-induced phosphorylation of CD18 in monocytes was 
largely due to [32P]phosphoserine,  with small amounts con- 
tributed by [32p]phosphothreonine and [32P]phosphotyrosine 
(Fig.  8  A).  Phosphorylation of CDlla  was  solely due  to 
[32p]phosphoserine (Fig. 8 B), in agreement with the pres- 
ence of serine as the only amino acid target for phospho- 
rylation  in  the  cytoplasmic end  of CDlla  (Fig.  1).  Only 
[32P]phosphoserine  contributed to  CDllb  phosphorylation 
under these conditions (Fig.  8 B),  while an abundance of 
p2p]phosphoserine  and  traces  of  p2p]phosphothreonine 
were detected in CDllc  (Fig.  8 B).  No p2P]phosphotyro- 
sine residues were detected in CD1 lb or CD1 lc. 
Discussion 
In this study, we determined the phosphorylation status of the 
various subunits of CD1 1/CD1  8 antigens in resting and acti- 
vated human monocytes and PMN. All three CD11 subunits 
were found to be constitutively phosphorylated. The basal 
phosphorylation level of CD1 1 subunits increased only mar- 
ginally  (1.0-1.6-fold)  upon  treatment  of  monocytes  with 
Chatila et at. Phosphorylation of CDI1/CD18  3439 phothreonine and  [32p]phosphotyrosine. CDll  phosphory- 
lation was either totally (CDlla,b) or mostly (CDIlc) due to 
[32Plphosphoserine. 
PMA induced a significant shift in the isofocusing profile 
of CD18 (Fig. 4).  Under baseline conditions, CD18 isofo- 
cused as one major (~75%) basic  species and one minor 
(,x,25 %) more acidic species (Fig. 4 A). Activation of mono- 
cytes with PMA resulted in a shift in the relative intensity 
of these two CD18  species  with the bulk of radioactivity 
(~75%) now associating with the more acidic form (Fig. 4 
B). Previous studies have shown variable amounts of these 
two forms by IEF-PAGE analysis and attributed this hetero- 
geneity to sialic acid content (there are six potential N-gly- 
cosylation sites  in  CD18)  (Sanchez-Madrid  et  al.,  1983; 
Hildreth and  August,  1985).  The present studies  identify 
phosphorylation as a major factor in the IEF-PAGE profile 
of CDI8 and also indicate that PMA-induced phosphoryla- 
tion of CD18 occurs with a  relatively high stoichiometry. 
Receptor-mediated activation of protein kinases is a  key 
mechanism by which extracellular ligands regulate cellular 
functions. In particular, activation of two pathways  of phos- 
phorylation, one mediated by PKC and the other by Ca++/ 
calmodulin-dependent kinases has emerged as a mechanism 
common to many activators of leukocytes such as  FMLP 
(Gerard et al.,  1986;  Hayakawa et al.,  1986;  Wright and 
Hoffman, 1987). Activation of these diverse protein kinases 
occurs through receptor-mediated accumulation of the sec- 
ond  messengers  inositol  triphosphate  and  DAG.  Inositol 
triphosphate induces an increase in [Ca++], resulting in the 
activation of multiple  Ca++-dependent  pathways  including 
Ca++/calmodulin-dependent kinases,  while DAG  is  an im- 
portant physiologic activator of PKC (Bell, 1986; Berridge, 
1987). Phorbol esters, such as PMA, are poorly hydrolyza- 
ble analogues of DAG that induce sustained activation of PKC 
Figure  4.  Stoichiometry of phosphorylation of surface-expressed 
CDIlb  and CDI8.  Untreated (resting) (A) or PMA-treated (B) 
surface-iodinated monoeytes were detergent lysed and immunopre- 
cipitated with anti-CDl lb mAb. Immunoprecipitates were analyzed 
by two-dimensional gel electrophoresis (IEF, in the first dimension; 
PAGE, in  the  second dimension)  followed by autoradiography. 
-  and +  indicate the acidic and basic ends of the isofocusing gel, 
respectively. Arrowheads indicate the  position of the molecular 
mass markers myosin (200 kD), phosphorylase b (92.5 kD), and 
BSA (68 kD). The position of the two major CD18 bands (arrows) 
as well as that of  the broad CDllb band (open arrowhead) are indi- 
cated. Densitometric scanning showed  that the proportion  of  the ba- 
sic and acidic forms of CD18 shown inA were 74 and 26%, respec- 
tively. After PMA treatment (B), the proportion became 27 and 
73% for the basic and acidic forms, respectively. 
PMA,  FMLP,  or the Ca  ++  ionophore ionomycin. In  con- 
trast, little or no constitutive phosphorylation of the common 
CD18  subunit was observed in [32P]-labeled  resting leuko- 
cytes. Cell activation with the adhesion-promoting stimuli 
PMA or FMLP led to a marked phosphorylation of CD18 
that was dose and time dependent and predominantly due to 
[32p]phosphoserine with  small  contributions by [32p]phos- 
Figure 5. Effect of FMLP (10  -7 M) on the kinetics of CDllb/CD18 
phosphorylation  in  human  monocytes. FMLP  induced  a  rapid 
phosphorylation of CD18 which peaked at 30 s and progressively 
declined to almost baseline levels by 5 min.  Changes in CDllb 
phosphorylation were minimal. This experiment is representative 
of two  independent experiments.  (Inset)  Autoradiograph of an 
SDS-polyacrylamide gel (7.5  %) showing the phosphorylation sta- 
tus of CD11b/CD18 in 32p-loaded monocytes in the absence (-) or 
presence (+) of FMLP (10  -7 M, 0.5 min, 37°C). 
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to ionomycin (50 riM), FMLP (10  -7 M), and PMA (250 ng/ml). 
32P-Labeled monocytes were untreated (C), or exposed to ionomy- 
cin (lono), FMLP, or PMA for 30 s at 37°C. CDI1/CDI8 were im- 
munoprecipitated  from detergent-solubilized  cells using the anti- 
CD18 mAb 10F12, and electrophoresed on a 10% polyacrylamide 
gel in SDS. The arabic numerals at the bottom of each lane reflect 
the levels of CD18 phosphorylation  (quantitated by densitometry) 
in response to various stimuli, with the baseline value assigned an 
arbitrary unit of 100. PMA and FMLP increased CD18 phosphory- 
lation by 4- and 2.3-fold,  respectively, above baseline levels. No 
significant change  in CD18 phosphorylation  was detected  in re- 
sponse to ionomycin. Similar results were observed in two other ex- 
periments. 
(Nishizuka,  1984).  The induction of CD18 phosphorylation 
by PMA  suggests that this  antigen  is a  substrate of PKC. 
FMLP-induced  phosphorylation,  on  the  other  hand,  may 
equally  result  from the  action  of Ca++/calmodulin-depen  - 
dent kinases that have been activated by the elevated [Ca+÷]~ 
as well as by PKC. To differentiate between these two possi- 
bilities, we examined the influence of an isolated increase in 
[Ca++]i, independent of PKC activation, on the phosphory- 
lation of CD11/CD18. Treatment of monocytes with ionomy- 
cin at 50 nM had no effect on the phosphorylation status of 
CDllb or CD18 (Fig. 6).  At this concentration,  ionomycin 
induced  an  increase  in  [Ca÷+]~ equal  to  or  exceeding  that 
noted  with  FMLP  (at  10  -6  M)  without  significantly 
influencing the activity of phospholipase C (data not shown; 
Preiss  et  al.,  1987).  This  suggests  that  FMLP-mediated 
phosphorylation of CD18 is not primarily related to the acti- 
vation  of Ca++/calmodulin-dependent  kinases  but  is  more 
likely due to DAG-mediated activation of PKC. 
The  magnitude  and  the  kinetics of PMA-induced  phos- 
phorylation  of  CD18  differed  from  those  observed  for 
FMLP.  At  optimal  concentrations,  PMA-induced  phos- 
phorylation was intense and sustained (Figs. 3 and 7 A) while 
that of FMLP was less intense and more transient in nature 
(Figs.  5  and 7  B).  The greater intensity of PMA-induced 
phosphorylation of  CD18 relative to that of FMLP may relate 
to the greater potency of PMA in activating PKC as com- 
pared with  DAG (Nishizuka,  1984).  The rapid decline  in 
FMLP-induced phosphorylation of CD18 may relate to the 
transient nature of DAG accumulation in FMLP-treated cells 
and/or activation ofphosphatases. The intracellular accumu- 
lation of DAG may be rapidly terminated by a  process of 
receptor  uncoupling  from phospholipase  C  (Allen  et  al., 
1988). 
While  stimulation  of monocytes  with  PMA  or  FMLP 
resulted in the predominant phosphorylation of CD18 on ser- 
ine/threonine residues, consistent with a direct PKC effect, 
it also resulted in the appearance of a  minor component of 
tyrosine phosphorylation (5-10%).  Activation of PKC has 
been reported to secondarily activate some tyrosine kinases 
(Gilmore and Martin, 1983), and it is possible that this is the 
mechanism  underlying  the  observed  [32p]phosphotyrosine 
in CD18 from activated cells. The nature of the responsible 
tyrosine kinase(s)  and the  role,  if any, that tyrosine phos- 
phorylation  plays  in  CD18  function  remains  to  be  deter- 
mined. 
PMA- or FMLP-induced phosphorylation of the common 
CD18 subunit followed similar kinetics to those observed for 
Figure 7. PMA- and FMLP-induced CDllb/ 
CDI 8 phosphorylation in human PMN. (A) 
Autoradiogmph  of CDllb/CDl8  immuno- 
precipitated from 32P-loaded PMN that were 
either left untreated (0 time point) or treated 
with PMA at 30 ng/ml for 15-60 rain. Im- 
munoprecipitates  were electrophoresed  on 
7.5%  polyacrylamide  gels  according  to 
Laemmli 0970). Densitometric scanning of 
[32P]CD18 and  [32P]CDllb at  15,  30,  and 
60 rain (compared to a baseline value of 100 
for each  subunit)  were  as  follows: [32p]_ 
CDI8: 1016, 1302, 1347; [32P]CDllb: 162, 
161, 148. (B) A similar analysis showing the 
phosphorylation  status of CDllb/CDl8  in 
PMN before (0 time point) or after (0.5-5 
rain) exposure to FMLP (10  -7 M).  Densi- 
tometric  scanning of [32p]CDI8 and [32p]_ 
CDllh  at 0.5, 2.5,  and  5  min (assuming 
baseline  values  of  100) were  as  follows: 
[32p]CD18: 203,  181, 178; [32p]CDllb: 95, 
112,  114. CD18 phosphorylation  induced 
by PMA (30  ng/ml,  5 min)  is shown for 
comparison. 
Chatila et al. Phosphorylation of CDll/CDI8  3441 Figure  &  Phosphoamino  acid  analysis of PMA- and 
FMLP-induced CDll/CDI8 phosphorylation. (,4) Phos- 
phoamino  acids  in  PMA- or  FMLP-phosphorylated 
CDIS.  Each  CD18 hydrolysate (see  Materials  and 
Methods) was  subjected separately to thin  layer elec- 
trophoresis in pH 3.5 buffer (first dimension,  l), then 
electrophoresed in pH 1.9 buffer (second dimension, 2). 
+ indicates direction of the anode in each case. After de- 
tecting the unlabeled carrier phosphoamino acids (with 
ninhydrin), cellulose filters were autoradiographed and 
the photographs (shown here) cropped to demonstrate the 
regions of interest. Trace amounts of [32p]phosphothreo- 
nine  and  [32p]phosphotyrosine were  detected  in  both 
PMA- and FMLP-induced phosphorylated CD18. Treat- 
ment of 32P-loaded monocytes with PMA (250 ng/ml) 
and FMLP (10  -6 M) were carried out for 15 min and 
30 s, respectively, at 37°C. (B) A similar analysis show- 
ing 32p-labeled amino acids in CDll subunits from 32p_ 
labeled monocytes activated with PMA (250 ng/ml,  15 
min, 37°C). [32p]Phosphoserine  was present in all CDll 
subunits. No [32p]phosphothreonine  or [32P]phosphoty- 
rosine was detected in CDlla or CDllb. Trace amounts 
of [32p]phosphothreonine  were detected in CDllc. 
enhanced cell adhesion induced by these same stimuli.  In 
particular, the onset of FMLP-induced CD18 phosphoryla- 
tion was maximal in 30 s,  and decreased by 5 min, a time 
course which closely parallels FMLP-induced homotypic or 
heterotypic adhesion in PMN (Boxer  et al., 1979; O'Flaherty 
et al., 1979; Smith et al.,  1979). Relatively little alterations 
in CD1 lb phosphorylation were observed under these condi- 
tions (Figs. 5 and 7 B). It is tempting to speculate, therefore, 
that the dramatic increase in CDll/CD18-dependent adhe- 
sion of activated leukocytes is mediated in part by stimulus- 
induced CD18 phosphorylation. The high stoichiometry of 
phosphorylation of surface-expressed CD18 (Fig. 4) is con- 
sistent with an important physiologic role for phosphoryla- 
tion in receptor function. Phosphorylation could, for exam- 
ple, explain, at least in part, the qualitative upregulation in 
CDI1/CD18 function which occurs in activated leukocytes or 
in cytoplasts (Wright and Silverstein, 1982; Patarroyo et al., 
1985; Vedder et al., 1988; Buyon et al., 1988). It could also 
be a mechanism for the observed dissociation between in- 
creased CDll/CD18 expression on the cell surface and re- 
duced cell adhesion in normal leukocytes and in certain my- 
eloid cell lines (Arnaout et al., 1985; Dana et al., 1987). The 
mechanism by which CD18 phosphorylation would promote 
CDll/CD18 adhesion-dependent functions is unclear. Like 
other integrins, CDll/CD18 may provide a transmembrane 
link between the extracellular environment and cytoskeleton. 
It is  conceivable that the phosphorylation status  of CD18 
could regulate receptor-cytoskeleton or perhaps receptor- 
ligand interactions. In other integrins, it has been suggested 
that their phosphorylation status may regulate their adhesive 
functions (Hirst et al.,  1986;  Dahl  and Grable,  1989).  In 
PMN, the ability of CDIlb/CD18 to bind to its ligand, iC3b, 
temporally correlated with the extent of ligand-independent 
receptor aggregation (clustering) induced by PMA (Detmers 
et al.,  1987). It has also been shown that the CDllb/CD18 
receptor acquires the ability to recognize coagulation factor 
X in activated but not resting monocytes (Altieri et al., 1988). 
It is also possible that phosphorylation may play a  role in 
receptor internalization as was shown in several other recep- 
tor systems (Klausner et al.,  1984; Begiunot et al.,  1985). 
The contribution of the intrinsic state of CD11 phosphoryla- 
tion and its variable increase upon stimulation to such inter- 
actions remains to be determined. Despite this temporal as- 
sociation, establishing a direct cause and effect relationship 
between  stimulus-induced  CD18  phosphorylation and  en- 
hanced cell adhesion would require additional studies on the 
functional properties of CD18 mutagenized in its cytoplas- 
mic serine, threonine, or tyrosine residues. This approach 
may also be helpful in delineating a possible role of intrinsic 
CDll phosphorylation in the regulation of CDll/CD18-me- 
diated leukocyte adhesion. 
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